查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632590

美国PRP 和干细胞治疗脱髮症市场：市场规模、份额、趋势分析（按治疗方法、适应症、最终用途和地区）、细分市场预测（2025-2030 年）

U.S. PRP And Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis Report By Treatment (Platelet Rich Plasma Therapy, Stem Cell Therapy), By Indication (Androgenic Alopecia, Alopecia Areata), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国PRP 和干细胞脱髮症市场的成长和趋势：

根据 Grand View Research 的新报告，到 2030 年，美国PRP 和干细胞脱髮症治疗市场规模预计将达到 4.3891 亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 9.46%。该市场的成长要素包括疾病意识的提高、治疗率的提高以及越来越多地采用可提供更好患者治疗效果的新治疗方法。此外，该疗法副作用发生率低，预计将推动对富血小板血浆 (PRP) 疗法和干细胞疗法的需求。

随着越来越多的患者青睐新治疗方法而非传统治疗方法，预计采用 PRP 和干细胞疗法治疗脱髮症的情况将会增加。除此之外，预计预测期内更短的治疗时间、更快的毛髮生长和改善的患者预后将推动对这些治疗方法的需求。

依治疗方法类型划分，2017 年 PRP 手术占比最大，以手术数量计算为 58.1%。然而，由于 PRP 程序的价格较低，干细胞治疗程序在 2017 年占据了主要的收益占有率，价值 7,010 万美元。根据最终用途，皮肤科诊所部门占 2017 年总市场收益的 85.0%，因为与医院相比治疗成本较低。

竞争环境包括橘郡头髮修復中心、科罗拉多州毛髮科学中心、Evolution 脱髮研究所、萨沃拉美容皮肤病学中心、PLC、NovaGenix、维吉尼亚外科中心和迈阿密毛髮移植研究所等诊所。

美国PRP 和干细胞脱髮症治疗市场：概述

  • 由于干细胞疗法在治疗脱髮和退化性疾病等各种疾病方面具有潜在应用价值，预计预测期内干细胞疗法将以 12.47% 的复合年增长率大幅增长。
  • 男性脱髮症将占据市场主导地位，到 2024 年将占据 71.51% 的最大收入份额，这是由于其患病率高，影响约 5000 万男性和 3000 万女性。
  • 由于皮肤病和男性脱髮症等脱髮症的盛行率不断上升，皮肤科诊所将占据市场主导地位，到 2024 年将占据 69.60% 的最大收入份额。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3美国。

  • 市场概况/相关展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 美国PRP 和干细胞治疗脱髮症市场：分析工具
    • 波特五力分析
    • PESTEL 分析

第脱髮症美国。

  • 细分仪表板
  • 美国PRP 和干细胞脱髮症治疗市场：按治疗方法进行趋势分析（2023 年和 2030 年）
  • 富血小板血浆疗法
  • 干细胞治疗

第 5 章美国PRP 和干细胞脱髮症治疗市场：按适应症进行的估计和趋势分析

  • 细分仪表板
  • 美国PRP 和干细胞治疗脱髮症市场：按适应症进行趋势分析（2023 年和 2030 年）
  • 男性脱髮症
  • 脱髮症
  • 脱髮症
  • 其他的

美国6 章。

  • 细分仪表板
  • 美国PRP 和干细胞治疗脱髮症市场：趋势分析，按最终用途（2023 年和 2030 年）
  • 医院
  • 皮肤科诊所
  • 其他的

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Bauman Medical Group, PA
    • Virginia Surgical Center
    • Nova Medical Hair Transplant
    • Chicago Hair Transplant Clinic
    • Dr. V Medical Aesthetics
    • City Facial Plastics
    • Orange County Hair Restoration
    • MAXIM Hair Restoration
    • New Jersey Hair Restoration Center
    • Hair Restoration Institute of Minnesota
    • Morgenstern Hair Restoration LLC.
Product Code: GVR-2-68038-594-6

U.S. PRP And Stem Cell Alopecia Treatment Market Growth & Trends:

The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.

By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.

The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.

U.S. PRP And Stem Cell Alopecia Treatment Market Report Highlights:

  • Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.
  • Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.
  • Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. PRP & Stem Cell Alopecia Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1 Increasing Prevalence of Alopecia
      • 3.3.1.2 Technological Advancements and Research in Regenerative Medicine
      • 3.3.1.3 Increasing Consumer Demand for Non-Invasive and Natural Treatments
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Regulatory and Legal Barriers
      • 3.3.2.2. High Cost of Treatment and Accessibility Issues
      • 3.3.2.3. Lack of Long-Term Clinical Evidence and Efficacy Data
  • 3.4. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Platelet Rich Plasma Therapy
    • 4.3.1. Platelet Rich Plasma Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Stem Cell Therapy
    • 4.4.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Androgenic Alopecia
    • 5.3.1. Androgenic Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Alopecia Areata
    • 5.4.1. Alopecia Areata Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cicatricial or Scarring Alopecia
    • 5.5.1. Cicatricial or Scarring Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Dermatology Clinics
    • 6.4.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Bauman Medical Group, P.A.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Product Benchmarking
      • 7.4.1.3. Recent Developments/ Strategic Initiatives
    • 7.4.2. Virginia Surgical Center
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Product Benchmarking
      • 7.4.2.3. Recent Developments/ Strategic Initiatives
    • 7.4.3. Nova Medical Hair Transplant
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Recent Developments/ Strategic Initiatives
    • 7.4.4. Chicago Hair Transplant Clinic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Recent Developments/ Strategic Initiatives
    • 7.4.5. Dr. V Medical Aesthetics
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Recent Developments/ Strategic Initiatives
    • 7.4.6. City Facial Plastics
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Product Benchmarking
      • 7.4.6.3. Recent Developments/ Strategic Initiatives
    • 7.4.7. Orange County Hair Restoration
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Product Benchmarking
      • 7.4.7.3. Recent Developments/ Strategic Initiatives
    • 7.4.8. MAXIM Hair Restoration
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Recent Developments/ Strategic Initiatives
    • 7.4.9. New Jersey Hair Restoration Center
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Recent Developments/ Strategic Initiatives
    • 7.4.10. Hair Restoration Institute of Minnesota
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Recent Developments/ Strategic Initiatives
    • 7.4.11. Morgenstern Hair Restoration LLC.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Product Benchmarking
      • 7.4.11.3. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. PRP & Stem Cell Alopecia Treatment Market, by Treatment, 2018 - 2030 (USD Million)
  • Table 4 U.S. PRP & Stem Cell Alopecia Treatment Market, by Indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. PRP & Stem Cell Alopecia Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Key companies undergoing collaboration and partnerships
  • Table 7 Key companies using other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 U.S. PRP & Stem Cell Alopecia Treatment Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis
  • Fig. 16 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Outlook and Key Takeaways
  • Fig. 17 PRP Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 18 Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 19 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis
  • Fig. 20 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Outlook and Key Takeaways
  • Fig. 21 Androgenic Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 22 Alopecia Areata Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 23 Cicatricial Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 24 Other Indications Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis
  • Fig. 26 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Outlook and Key Takeaways
  • Fig. 27 Dermatology Clinics Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Other End Use Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 U.S. PRP & Stem Cell Alopecia Treatment Market Movement Analysis by Region